Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Coherus Bio (CHRS)

Coherus Bio (CHRS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
4 Biotech Stocks That Could Keep Beating Wall Street

The biotechnology industry has lagged the broader market so far this year, but these four stocks have done pretty well and should continue to do so.

BMY : 58.15 (+0.22%)
LLY : 112.80 (-0.64%)
ACAD : 45.24 (+6.17%)
CHRS : 18.80 (-1.36%)
CELG : 109.57 (+0.03%)
BIIB : 294.14 (+0.30%)
INCY : 84.86 (-0.28%)
ADPT : 28.32 (+2.65%)
ALEC : 16.68 (-2.51%)
NGM : 12.82 (+1.26%)
TAK : 19.73 (-1.69%)
Coherus BioSciences Announces New Employment Inducement Grants

Coherus BioSciences, Inc. ("Coherus" or the "Company", Nasdaq: CHRS), today announced that effective November 7, 2019, the compensation committee of the Company's board of directors granted options to...

CHRS : 18.80 (-1.36%)
Coherus Bioscien has the Best Relative Performance in the Biotechnology Industry (CHRS , VNDA , ATRA , EPZM , RDUS )

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

ATRA : 13.05 (-2.61%)
CHRS : 18.80 (-1.36%)
VNDA : 14.88 (+0.95%)
SmarTrend Watching for Potential Pullback in Shares of Coherus Bioscien After 3.14% Gain

Coherus Bioscien (NASDAQ:CHRS) traded in a range yesterday that spanned from a low of $17.42 to a high of $19.49. Yesterday, the shares gained 3.1%, which took the trading range above the 3-day high...

CHRS : 18.80 (-1.36%)
Coherus BioSciences (CHRS) Q3 Earnings and Revenues Surpass Estimates

Coherus BioSciences (CHRS) delivered earnings and revenue surprises of 75.00% and 19.35%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?...

CHRS : 18.80 (-1.36%)
Coherus Acquires Commercial Rights for Leading Lucentis Biosimilar in the United States

Coherus BioSciences, Inc. ("Coherus" or the "Company", Nasdaq: CHRS), today announced the Company has acquired exclusive rights from Bioeq IP AG, ("Bioeq") a Swiss biopharmaceutical joint venture, to commercialize...

CHRS : 18.80 (-1.36%)
Coherus BioSciences Reports Corporate Highlights and Third Quarter 2019 Financial Results

Coherus BioSciences, Inc. ("Coherus" or the "Company", Nasdaq: CHRS), today reviewed corporate highlights and reported financial results for the quarter ended September 30, 2019.

CHRS : 18.80 (-1.36%)
Investors Can Find Strong Stocks with our First Profit Screen

Investors Can Find Strong Stocks with our First Profit Screen

KOS : 7.31 (-0.27%)
FB : 189.61 (-0.64%)
CRSP : 50.91 (+0.73%)
CPRX : 5.02 (-0.99%)
CHRS : 18.80 (-1.36%)
BRFS : 8.34 (+1.58%)
AAPL : 262.20 (+0.79%)
% Return Seen to Date on SmarTrend Coherus Bioscien Call (CHRS)

SmarTrend identified a Downtrend for Coherus Bioscien (NASDAQ:CHRS) on October 10th, 2019 at $18.91. In approximately 2 weeks, Coherus Bioscien has returned 10.66% as of today's recent price of $16.89....

CHRS : 18.80 (-1.36%)
Coherus BioSciences Announces New Employment Inducement Grants

Coherus BioSciences, Inc. ("Coherus" or "the Company", Nasdaq: CHRS), today announced that effective October 17, 2019, the compensation committee of the Company's board of directors granted options to...

CHRS : 18.80 (-1.36%)
Amag Pharmaceuti is Among the Companies in the Biotechnology Industry with the Best Relative Performance (AMAG , CHRS , KPTI , EXAS , EXEL )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

AMAG : 9.25 (-1.39%)
CHRS : 18.80 (-1.36%)
KPTI : 15.28 (+3.80%)
Coherus BioSciences to Report Third Quarter Financial Results on November 6th

Coherus BioSciences, Inc. ("Coherus" or "the Company", Nasdaq: CHRS), today announced that its third quarter 2019 financial results will be released after market close on Wednesday, November 6, 2019. Starting...

CHRS : 18.80 (-1.36%)
Coherus Bioscien Set to Possibly Rebound After Yesterday's Selloff of 5.29%

Coherus Bioscien (NASDAQ:CHRS) traded in a range yesterday that spanned from a low of $19.47 to a high of $20.64. Yesterday, the shares fell 5.3%, which took the trading range below the 3-day low of...

CHRS : 18.80 (-1.36%)
Best Relative Performance in the Biotechnology Industry Detected in Shares of Sarepta Therapeu (SRPT , NTRA , CHRS , BLUE , PTCT )

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

CHRS : 18.80 (-1.36%)
NTRA : 37.34 (+1.25%)
SRPT : 94.78 (-1.56%)
Look for Shares of Coherus Bioscien to Potentially Pullback after Yesterday's 4.38% Rise

Coherus Bioscien (NASDAQ:CHRS) traded in a range yesterday that spanned from a low of $20.70 to a high of $22.00. Yesterday, the shares gained 4.4%, which took the trading range above the 3-day high...

CHRS : 18.80 (-1.36%)
Shares of Aimmune Therapeu Rank the Highest in Terms of Relative Performance in the Biotechnology Industry (AIMT , CHRS , HRTX , KPTI , CARA )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

AIMT : 28.82 (-2.24%)
CHRS : 18.80 (-1.36%)
HRTX : 20.59 (-4.10%)
First Week of CHRS May 2020 Options Trading

Investors in Coherus BioSciences Inc saw new options begin trading this week, for the May 2020 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the...

CHRS : 18.80 (-1.36%)
Adamas Pharmaceu has the Best Relative Performance in the Biotechnology Industry (ADMS , AMAG , CHRS , XNCR , INCY )

Below are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have the...

ADMS : 5.39 (-4.26%)
AMAG : 9.25 (-1.39%)
CHRS : 18.80 (-1.36%)
Coherus BioSciences Announces New Employment Inducement Grants

Coherus BioSciences, Inc. (Nasdaq: CHRS), today announced that effective September 19, 2019, the compensation committee of the company's board of directors granted 7 new employees options to purchase an...

CHRS : 18.80 (-1.36%)
Investors Can Find Big Returns with this First Profit Screen

Investors Can Find Big Returns with this First Profit Screen

LIQT : 6.90 (-4.56%)
IRWD : 11.11 (+0.82%)
DBD : 8.06 (-3.12%)
CPRX : 5.02 (-0.99%)
CHRS : 18.80 (-1.36%)

Van Meerten Stock Picks

The 5 Best Large Caps
I wanted to find which Large Caps had the best momentum so I used Barchart to sort the S&P 500 Large Cap Index first by the highest technical buy signals, then by the most frequent number of new highs in the last month.
CCI +0.30 , AIZ -0.99 , SBAC +0.16 , SO -0.79 , WELL +0.23
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar